Brief: Sernova increases private placement to $4.2 mln
June 29 (Reuters) - Sernova Corp SVA.V
* Announces that it is increasing its non-brokered private
placement to $4.2 million equal to 16.8 million units at $0.25
per unit
* Sernova increases private placement to $4,200,000
Source text for Eikon: ID:nMKWls7g2a
Further company coverage: SVA.V
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints